Limited Role for COX-2, TNFi in Reducing AxSpA Progression

There was a strong, but not statistically significant, signal of reduced spinal structural damage with the combination of a selective COX-2 inhibitor and a TNF inhibitor in axial spondyloarthritis.

Related Keywords

Berlin ,Germany ,Belgium ,Walterp Maksymowych , ,University Of Alberta ,University Medicine ,International Congress On Spondyloarthritides ,Fabian Proft ,International Congress ,Stoke Ankylosing Spondylitis Spinal Score ,Statistical Significance ,Numerical Difference ,Ankylosing Spondylitis Disease Activity Score ,Ankylosing Spondylitis ,Acute Pain ,Ankylosing Spondylitis Bechterews Disease ,Cox 2 Inhibitor ,Yclooxygenase 2 Inhibitor ,Pain Management ,Nonsteroidal Anti Inflammatory Drugs Nsaids ,Nonsteroidal Anti Inflammatory Drugs ,Nsaids ,Rug Nonsteroidal Anti Inflammatory ,Anti Inflammatory Agents ,Disease Modifying Antirheumatic Drugs Dmards ,Mard Disease Modifying Antirheum ,